ArticleMolecular therapy oncolytics2021

Preclinical evaluation of a novel antibody-drug conjugate targeting DR5 for lymphoblastic leukemia therapy.

Shuyong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.